SCHEMBL5936675

SCHEMBL5936675

O=C(Nc1cc[c]cc1)c1cccc(OCc2ccc(OCc3ccccc3)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 4/20 0.67
RAB9A P51151 3/20 0.67
NPC1 O15118 2/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
KMT2A Q03164 7/20 0.65
MEN1 O00255 6/20 0.65
RXFP1 Q9HBX9 2/20 0.63
SMPD1 P17405 2/20 0.62
MAPT P10636 5/20 0.61
LMNA P02545 3/20 0.61
USP2 O75604 1/20 0.59
MAPK1 P28482 1/20 0.59
ESR2 Q92731 1/20 0.59
TAAR1 Q96RJ0 1/20 0.59
GUSB P08236 1/20 0.58
HPGD P15428 1/20 0.57
HTT P42858 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5936638 0.94 NR1H4 (0.69) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL27966079 0.84 NR1H4 (0.71) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL5936672 0.83 SMPD1 (0.60) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7078440 0.82 NR1H4 (0.72) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL15838871 0.82 SMPD1 (0.77) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL4964241 0.81 NPC1 (1.00) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL9415806 0.81 NR1H4 (1.00) NR1H4RAB9ANPC1KMT2AMEN1
SCHEMBL11550139 0.80 NR1H4 (0.81) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL1123450 0.80 SMPD1 (0.59) NR1H4RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7076430 0.80 KMT2A (0.65) NR1H4RAB9ANPC1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG NR1H4 160/4885RAB9A 4567/4885NPC1 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.